NASDAQ
Pasithea Therapeutics Corp. (KTTA) has a free cash flow growth of 11.30% as of Friday, May 29, 2026. This represents a 139.94% increase compared to its 12-month average of -28.28%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.